The tumor suppressor gene ARRDC3 was markedly upregulated in all three models after selinexor treatment (Figure 4, Supplementary Table 1 consistent with previous studies performed in triple negative breast cancer cells (60). The gene discussed is ARRDC3; the disease is triple-negative breast carcinoma.